Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06928233

Association of TNFAIP3 With Immune-mediated TTP

Association of the TNFAIP3 Genomic Locus With Immune-mediated TTP

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
400 (estimated)
Sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Academic / Other
Sex
All
Age
12 Years
Healthy volunteers
Accepted

Summary

This study aims to investigate whether genetic variation in the TNFAIP3 locus is associated with immune-mediated thrombotic thrombocytopenic purpura (iTTP), and whether such association is mediated by decreased expression of A20 (TNFAIP3). The study includes a case-control design to assess genotype-expression association and a cohort study to evaluate clinical outcomes such as disease relapse.

Conditions

Interventions

TypeNameDescription
PROCEDUREblood samplingBlood sampling for experimental analyses.

Timeline

Start date
2025-04-07
Primary completion
2026-04-01
Completion
2026-04-01
First posted
2025-04-15
Last updated
2026-03-27

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06928233. Inclusion in this directory is not an endorsement.

Association of TNFAIP3 With Immune-mediated TTP (NCT06928233) · Clinical Trials Directory